Search

everythinglearnresearchcommunity

for

Search:↓

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

A mutation in the IKZF1 gene causes immune system overactivity, linked to autoimmune diseases like lupus.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

The skin and thymus develop similarly to protect and support immunity.

Hair growth phase in mice weakens certain immune responses.

Monocyte-derived dendritic cells play a key role in UVB-induced skin sensitivity and inflammation.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Thymus-derived Tregs, not peripherally-derived Tregs, primarily regulate type 1 diabetes in the NOD mouse model.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

The role of γδT-cells in causing alopecia areata remains unclear.

Blocking interferon-gamma might help treat various autoimmune diseases.

Tridax procumbens plant parts boost immune response in mice.

Trichohyalin may trigger the immune response causing alopecia areata.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

IL-17 inhibitors are more effective than methotrexate in preventing psoriatic arthritis in psoriasis patients.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.